The effect of hyperbaric oxygen therapy on central macular thickness and choroidal thickness in the healthy eyes of patients with idiopathic sudden sensorineural hearing loss

References

• Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996; 29:393–405.
   PubMed Web of Science ®Google Scholar
• Imsuwansri T, Poonsap P, Snidvongs K. Hyperbaric oxygen therapy for sudden sensorineural hearing loss after failure from oral and intratympanic corticosteroid. Clin Exp Otorhinolaryngol 2012; 5 Suppl 1:S99–S102.
   PubMed Web of Science ®Google Scholar
• Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980; 106:772–776.
   PubMed Web of Science ®Google Scholar
• Olex-Zarychta D. Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss. Ijms 2020; 21:8588.
   Google Scholar
• Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146:S1–S35.
   PubMed Web of Science ®Google Scholar
• Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 1998; 54:86–99.
   PubMedGoogle Scholar
• Herrera M, García Berrocal JR, García Arumí A, et al. Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss. Acta Otorrinolaringol Esp (Engl Ed) 2019;70:290–300.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Suzuki H, Shiomori T, et al. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2007; 264:861–866.
   PubMed Web of Science ®Google Scholar
• Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 2004; 261:393–396.
   PubMed Web of Science ®Google Scholar
• Alimoglu Y, Inci E, Edizer DT, et al. Eficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid and hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011; 268:1735–1741.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Mori T, Hashida K, et al. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011; 268:497–500.
   PubMed Web of Science ®Google Scholar
• Oguz H, Sobaci G. The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 2008; 53:112–120.
   PubMed Web of Science ®Google Scholar
• McMonnies C. Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy. J Optom 2018; 11:3–9.
   PubMedGoogle Scholar
• Benedetti S, Lamorgese A, Piersantelli M, et al. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 2004; 37:312–317.
   PubMed Web of Science ®Google Scholar
• Sheikh AY, Gibson JJ, Rollins MD, et al. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg 2000; 135:1293–1297.
   PubMed Web of Science ®Google Scholar
• McMonnies CW. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications. Clin Exp Optom 2015; 98:122–125.
   PubMed Web of Science ®Google Scholar
• Kaldırım H, Yazgan S, Ceylan B, Atalay K. The effect of hyperbaric oxygen therapy on retinal thickness and progression of retinopathy in patients with type 2 diabetes: a prospective cohort study. Cutan Ocul Toxicol 2019; 38:233–239.
   PubMed Web of Science ®Google Scholar
• Shaia FT, Sheehy JL. Sudden sensori-neural hearing impairment: a report of 1220 cases. Laryngoscope 1976; 86:389–398.
   PubMed Web of Science ®Google Scholar
• Oztürk F, Ermertcan AT, Inanir I. Hyperbaric oxygen therapy for the management of chronic wounds. Cutan Ocul Toxicol 2013; 32:72–77.
   PubMed Web of Science ®Google Scholar
• Goldstein LJ. Hyperbaric oxygen for chronic wounds. Dermatol Ther 2013; 26:207–214.
   PubMed Web of Science ®Google Scholar
• Chang YH, Chen PL, Tai MC, et al. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy. Clin Exp Ophthalmol 2006; 34:584–589.
   PubMed Web of Science ®Google Scholar
• Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica 1996; 210:168–170.
   PubMed Web of Science ®Google Scholar
• He Y, Ren XJ, Hu BJ, et al. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. BMC Ophthalmol 2018; 18:121.
   PubMed Web of Science ®Google Scholar
• Hu Q, Li H, Xu W, et al. Comparison between ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: a systematic review and meta-analysis of randomized controlled trials. Indian J Ophthalmol 2019; 67:1800–1809.
   PubMed Web of Science ®Google Scholar
• Nylander G, Lewis D, Nordström H, Larsson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 1985; 76:596–603.
   PubMed Web of Science ®Google Scholar
• Jacobson I, Harper AM, McDowall DG. The effects of oxygen under pressure on cerebral blood-flow and cerebral venous oxygen tension. Lancet 1963; 2:549.
   PubMed Web of Science ®Google Scholar
• van der BR, Çalişkan M, van Hulst RA, et al. Blood pressure ıncrease during oxygen supplementation in chronic kidney disease patients ıs mediated by vasoconstriction ındependent of baroreflex function. Front Physiol 2017; 30:186.
   Google Scholar
• Heyboer Rd M, Wojcik SM, Smith G, Santiago W. Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment. Undersea Hyperb Med 2017; 44:93–99.
   PubMed Web of Science ®Google Scholar
• Greaves MW. Anti-inflammatory action of corticosteroids. Postgrad Med J 1976; 52:631–633.
   PubMed Web of Science ®Google Scholar
• Aksoy M, Yilmaz G, Vardarli I, Akkoyun I. Choroidal thickness after dexamethasone ımplant or aflibercept in patients with diabetic macular edema persistent to ranibizumab. J Ocul Pharmacol Ther 2020; 36:629–635.
   PubMed Web of Science ®Google Scholar
• Cheung IMY, McGhee CNJ, Sherwin T. A new perspective on the pathobiology of keratoconus: interplay of stromal wound healing and reactive speciesassociated processes. Clin Exp Optom 2013; 96:188–196.
   PubMed Web of Science ®Google Scholar
• Beatty S, Koh H-H, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of agerelated macular degeneration. Surv Ophthalmol 2000; 45:115–134.
   PubMed Web of Science ®Google Scholar
• Shoham A, Hadziahmetovic M, Dunaief JL, et al. Oxidative stress in diseases of the human cornea. Free Radic Biol Med 2008; 45:1047–1055.
   PubMed Web of Science ®Google Scholar